[1,2,4]Triazolo[1,5-a]pyridine-6-boronic Acid Pinacol Ester
Product Information
Molecular Formula
C12H16N3O2B
Molecular Weight
245.09
Description
[1,2,4]Triazolo[1,5-a]pyridine-6-boronic Acid Pinacol Ester (CAS# 1160790-18-0) is a useful research chemical.
Synonyms
6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridine; 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridine
IUPAC Name
6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridine
SMILES
B1(OC(C(O1)(C)C)(C)C)C2=CN3C(=NC=N3)C=C2
InChI
InChI=1S/C12H16BN3O2/c1-11(2)12(3,4)18-13(17-11)9-5-6-10-14-8-15-16(10)7-9/h5-8H,1-4H3
InChI Key
QXPSJGKDBGYOEX-UHFFFAOYSA-N
Melting Point
109-114 °C
Purity
95 %
Storage
2-8 °C
LogP
1.02850
Safety Information
Precautionary Statement
P264, P280, P302+P352, P305+P351+P338, P312, P322, P337+P313, P363, and P501
Signal Word
Warning
Computed Properties
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
4
Rotatable Bond Count
1
Exact Mass
245.1335569 g/mol
Monoisotopic Mass
245.1335569 g/mol
Topological Polar Surface Area
48.6Ų
Heavy Atom Count
18
Formal Charge
0
Complexity
321
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| WO-2021222556-A1 | PI3K-α INHIBITORS AND METHODS OF USE THEREOF | 2020-04-29 |
| CN-112694477-A | Pyrazolo ring compound, pharmaceutical composition containing same, preparation method and application thereof | 2019-10-22 |
| WO-2020247804-A1 | Heterocycle substituted pyridine derivative antifungal agents | 2019-06-07 |
| KR-20210080461-A | Substituted Indole and Indazole Compounds | 2018-10-24 |
| KR-20200096941-A | Heterocycle-substituted pyridine derivatives antifungal agents | 2017-12-07 |
| US-2021163461-A1 | Heterocycle substituted pyridine derivative antifungal agents | 2017-12-07 |
| US-2020239465-A1 | Fused ring derivative as a2a receptor inhibitor | 2017-09-28 |
| EP-3527570-A1 | Five-membered heteroaryl ring bridged ring derivative, preparation method therefor and medical use thereof | 2016-10-14 |
| JP-2019534266-A | Bridged ring derivative of 5-membered heteroaryl ring, process for its preparation and medical use thereof | 2016-10-14 |
| US-2020055852-A1 | Five-membered heteroaryl ring bridged ring derivative, preparation method therefor and medical use thereof | 2016-10-14 |
